📰 Travis Frey News
Page 2 - Travis Frey News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Travis Frey. Real-time updates on events, politics, business and more.
November 4, 2021
/PRNewswire/ -- Calyxt, Inc. (NASDAQ: CLXT), a plant-based synthetic biotechnology company, today announced financial results for its third quarter ended...
October 5, 2021
/PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biotechnology company, today announced the launch of a strategic initiative that will...
May 7, 2021
On Monday, Tilray, Inc. (NASDAQ:TLRY) and Aphria, Inc. (NASDAQ:APHA) closed their merger after months of negotiations, creating a company with a combined market cap of $3.3 billion. Benzinga spoke with Irwin Simon, CEO of the new combined company. Check out the video below: Following the merger, Jefferies upgraded the rating for Tilray from Underperform to Buy, while raising the price target from $4.77 to $23. Jazz Pharmaceuticals (NASDAQ:JAZZ) finalized its acquisition of GW Pharmaceutical...
May 4, 2021
Next Generation Premium Soybean Product Line Contains Ultra-Low Levels of Linolenic Acid Positioning it to be the Most Stable Premium Soybean Oil Available on the Market R&D Advancement with Complex
April 29, 2021
New Hemp Transformation Technology Unlocks Capabilities to Selectively Breed and Deliver Improvements in Hemp Traits for Key Markets Including Protein, Fiber, Advanced Materials and Wellness Patent-Pending
April 20, 2021
Calyxt to Present at Upcoming Investor and Industry Conferences Calyxt, Inc . (NASDAQ:CLXT), a plant-based technology company, will participate in the following investor and industry conferences during the month of May 2021: 2021 American Oil Chemists Society (AOCS) Annual Meeting & Expo Date: May 4, 2021 Format: Featured Session Conference website here Date: May 11-12, 2021 Conference website here Date: May 25-26, 2021 Format: Fireside chat and 1x1s Speaker: Bill Koschak, Chief Financial Offic...
February 25, 2021
Bill Oxford / iStock / Getty Images Plus We know hundreds of times less or thousands of times less about the genomics of plants than we know about human genetics. As an internationally recognized expert in the field of gene editing, Rodolphe Barrangou emphasizes that the knowledge of such groundbreaking technologies as CRISPR is only partial when it comes to plants as compared to the knowledge of gene editing in humans. “We know hundreds of times less or thousands of...